Organ preservation and late functional outcome in oropharyngeal carcinoma: Rationale of eortc 1420, the “best of” trial

Jean Jacques Stelmes, Vincent Gregoire, Vincent Vander Poorten, Wojciech Golusiñski, Mateusz Szewczyk, Terry Jones, Mohssen Ansarin, Martina A. Broglie, Roland Giger, Jens Peter Klussmann, Mererid Evans, Jean Bourhis, C. René Leemans, Giuseppe Spriano, Andreas Dietz, Keith Hunter, Frank Zimmermann, Ingeborg Tinhofer, Joanne M. Patterson, Silvana QuagliniAnne Sophie Govaerts, Catherine Fortpied, Christian Simon

Research output: Contribution to journalArticleAcademicpeer-review

27 Citations (Scopus)


Dysphagia represents one of the most serious adverse events after curative-intent treatments with a tremendous impact on quality of life in patients with head and neck cancers. Novel surgical and radiation therapy techniques have been developed to better preserve swallowing function, while not negatively influencing local control and/or overall survival. This review focuses on the current literature of swallowing outcomes after curative treatment strategies. Available results from recent studies relevant to this topic are presented, demonstrating the potential role of new treatment modalities for early-and intermediate-stage oropharyngeal cancers. Based on this, we present the rationale and design of the currently active EORTC 1420 “Best of” trial, and highlight the potential of this study to help prioritizing either surgery-or radiation-based treatment modalities for the treatment of oropharyngeal cancer in the future.

Original languageEnglish
Article number999
JournalFrontiers in Oncology
Issue numberOCT
Publication statusPublished - 22 Oct 2019


  • EORTC 1420
  • Functional outcome
  • Head and neck cancer
  • Organ preservation
  • Oropharyngeal cancer

Cite this